- Home
- ALT vs FRPH Comparison
ALT vs FRPH Comparison
Compare ALT & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALT | FRPH |
|---|---|---|
| Founded | 1997 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 415.3M | 435.3M |
| IPO Year | 2005 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ALT | FRPH |
|---|---|---|
| Price | $3.86 | $22.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $15.50 | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 38.0K |
| Earning Date | 06-10-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.37 | N/A |
| EPS | N/A | ★ 0.16 |
| Revenue | $41,000.00 | ★ $41,774,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $756,308.50 | N/A |
| P/E Ratio | ★ N/A | $145.47 |
| Revenue Growth | ★ 105.00 | 0.65 |
| 52 Week Low | $2.91 | $21.68 |
| 52 Week High | $7.73 | $29.68 |
Technical Indicators
Market Signals| Indicator | ALT | FRPH |
|---|---|---|
| Relative Strength Index (RSI) | 38.30 | 35.81 |
| Support Level | $3.78 | $21.93 |
| Resistance Level | $3.88 | $24.61 |
| Average True Range (ATR) | 0.25 | 0.52 |
| MACD | -0.07 | -0.15 |
| Stochastic Oscillator | 32.34 | 18.97 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).